Delivra Health Brands (DHB) Corporate Presentation summary

Business overview and vision

• Focuses on alternative wellness solutions with brands addressing chronic pain, anxiety, and sleeplessness.

• Vision is to build a community of wellness naturally, pioneering innovative products for everyday health issues.

• Leverages OTC brand equity in both non-infused and infused markets, supported by intellectual property.

• Operates a lean, asset-light model with in-house product innovation and outsourced manufacturing.

• Significant North American growth and expanding global distribution network.

Product portfolio and differentiation

• DreamWater offers a fast-acting, naturally derived sleep solution with GABA, melatonin, and 5-HTP.

• LivRelief provides clinically proven, plant-based transdermal creams for chronic pain relief, using a proprietary delivery system.

• LivRelief Infused delivers CBD, THC, and other actives for targeted, long-lasting pain relief.

• Both brands have strong consumer testimonials and high repeat usage.

• Over 35 million DreamWater units and 2.5 million LivRelief units sold globally.

Market opportunity and growth strategy

• Global OTC sleep aid market projected to grow from $30B in 2023 to $53B by 2032.

• Topical pain relief market expected to reach $16.45B by 2032, growing at 5% annually.

• Strategy includes digital marketing, e-commerce, shelf space investment, and global expansion.

• Asset-light model enables rapid scaling and efficient capital allocation.

• Established partnerships with major retailers and e-commerce platforms.